Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Basis of Presentation (Details Narrative)

v3.19.2
Nature of Operations and Basis of Presentation (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 19, 2019
Apr. 11, 2019
Jan. 24, 2019
Dec. 17, 2018
Nov. 14, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Common stock, par value           $ 0.0001   $ 0.0001   $ 0.0001
Anti-dilution shares embedded           10,342,260 868,119 6,248,988 812,287  
Operating loss           $ (2,017,987) $ (1,992,235) $ (4,033,410) $ (2,741,283)  
Cash outflow from operations               (6,129,933) $ (1,329,850)  
Cash           $ 1,023,913   $ 1,023,913   $ 5,459,884
Subsequent Event [Member]                    
Proceeds from convertible note $ 5,000,000                  
Investors [Member] | Series C Convertible Preferred Stock [Member]                    
Conversion of common stock   4,268,000                
Conversion of stock, description   The shares of Series C Convertible Preferred Stock are convertible into 4,268,000 shares of the Company's common stock, and rights to convert into common stock are subject to limitations on ownership at any one time of Company common stock up to 9.9% of the issued and outstanding shares of common stock of the Company; otherwise, the Series C Convertible Preferred Stock has no rights not awarded to holders of common stock of the Company.                
Over-Allotment Option [Member] | Underwriting Agreement [Member]                    
Common stock, par value       $ 0.0001            
Option to purchase shares of common stock       25,000            
Exercise price per share       $ 4.98            
Proceeds from over allotment options       $ 121,909            
Commission and expenses       $ 10,601            
Class A Unit [Member] | IPO [Member]                    
Initial public offering, shares         2,670,000          
Common stock, par value         $ 0.0001          
Warrants price per share         $ 5.00          
Proceeds from initial public offering         $ 12,415,500          
Underwriting discounts and commission         934,500          
Stock issuance cost         $ 743,765          
Series A Warrant [Member]                    
Warrants to purchase common stock         1          
Series B Warrant [Member]                    
Warrants to purchase common stock         1          
Conversion of common stock           2,404,692   4,156,300    
Series A Warrants [Member] | Investors [Member]                    
Warrants to purchase common stock   1,189,560 508,940              
Conversion of common stock     508,940              
Series A Warrants [Member] | Underwriting Agreement [Member]                    
Warrants to purchase common stock       400,500            
Warrants price per share       $ 0.01            
Series A Warrants [Member] | Exchange Agreements [Member]                    
Warrants to purchase common stock     424,116              
Stock issuance cost     $ 159,958              
Gross proceeds of warrant     $ 2,172,680              
Series B Warrants [Member] | Investors [Member]                    
Warrants to purchase common stock   1,005,760                
Anti-dilution shares embedded   4,268                
Series B Warrants [Member] | Underwriting Agreement [Member]                    
Warrants to purchase common stock       400,500            
Warrants price per share       $ 0.01            
New Warrants [Member] | Investors [Member]                    
Warrants to purchase common stock     933,056              
Warrants price per share     $ 3.67